By Scott Kanowsky Investing.com -- Shares in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rose on Friday after the drugmaker posted better-than-expected earnings in the fourth...
(Reuters) -Regeneron Pharmaceuticals Inc reported a better-than-expected fourth-quarter profit on Friday, as strong demand for eczema drug Dupixent helped shield a drop in U.S....
By Geoffrey Smith Investing.com -- Stocks in focus in premarket trading on Friday 3rd February. Please refresh for updates. Apple (NASDAQ:AAPL) stock fell 1.5% after the iPhone...
Let's be frank: The third quarter was a mess for stocks. It doesn't much matter where the stocks were traded, except this: U.S. stocks in September were not a place you wanted to...
What’s in a name? If you are interested in the tech sector, maybe the better question is: What’s in an acronym? Because it’s the acronym that spells out just who the cool kids...
Stocks surged in July, with the major indexes enjoying their best gains since 2020. But the market is still off substantially for the year. The rally came despite the Federal...
Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.
| Average | 816.35 (+4.24% Upside) |
| High | 1,023.00 |
| Low | 605.00 |
| Price | 783.13 |
| No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Sell | Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 189.98 | 199.00 | 183.69 | +1.71 | +0.91% | 230.29M | NASDAQ | |||
| 257.93 | 260.45 | 257.19 | -2.61 | -1.00% | 244.03K | NYSE | |||
| 35.15 | 35.77 | 34.97 | -0.05 | -0.14% | 10.28M | NYSE | |||
| 0.0003 | 0.0003 | 0.0003 | 0.00 | 0.00% | 3.32M | OTC Markets | |||
| 2.82 | 3.13 | 1.88 | +0.86 | +43.88% | 45.28M | NASDAQ | |||
| 46.02 | 46.88 | 45.75 | -1.22 | -2.58% | 3.50M | NASDAQ | |||
| 228.09 | 229.88 | 226.48 | -3.22 | -1.39% | 2.00M | NYSE | |||
| 9.99 | 10.09 | 9.95 | -0.08 | -0.79% | 30.20K | NYSE | |||
| 77.47 | 81.14 | 76.57 | -3.80 | -4.68% | 2.78M | NASDAQ | |||
| 58.30 | 59.13 | 57.96 | +0.67 | +1.16% | 5.72M | NYSE | |||
| 21.09 | 21.26 | 20.53 | -0.18 | -0.85% | 129.81K | NYSE | |||
| 13.00 | 13.00 | 13.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 34.39 | 34.58 | 33.96 | +0.46 | +1.36% | 1.60M | NYSE | |||
| 63.26 | 63.73 | 62.49 | +0.20 | +0.32% | 1.54M | NYSE | |||
| 80.89 | 83.25 | 79.40 | -1.23 | -1.50% | 8.46M | NASDAQ |